Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 11 Sept, 01:30 am
ServiceTitan (NASDAQ: TTAN) fell after issuing a third-quarter revenue forecast below analysts’ expectations—not because of a law-firm investigation. BridgeBio Oncology Therapeutics (NASDAQ: BBOT) and The Bancorp (NASDAQ: TBBK) declined following clinical-program deve
Positive clinical data, strong earnings, higher financial guidance, and Nasdaq compliance announcements drove several notable stock gains. Leading movers included Opus Genetics (NASDAQ: IRD) , ODDITY Tech (NASDAQ: ODD) , Signet Jewelers (NYSE: SIG) , and bioAffinity Technologies
Caleres (NYSE: CAL) reported robust earnings per share (EPS) of $0.47 , significantly exceeding analyst estimates. Despite strong EPS, the footwear company's revenue of $695.45 million fell short of consensus expectations, highlighting mixed financial performance . Growth in the
Macy’s (NYSE: M) will report its second-quarter fiscal 2026 results on September 10, 2026. Analysts expect approximately $0.37 in adjusted earnings per share (EPS) and $4.81 billion in net sales , compared with company guidance of $0.29–$0.34 per share and $4.75&ndash
Wells Fargo lowered its price target for Casey’s General Stores (NASDAQ: CASY) to $750 from $960 while maintaining an Overweight rating. Casey’s General Stores (NASDAQ: CASY) shares fell nearly 15% after fiscal first-quarter inside same-store sales growth of 3.2% miss
Wells Fargo maintained an Equal Weight rating on Signet Jewelers (NYSE: SIG) while raising its price target to $100 from $90 . Signet Jewelers (NYSE: SIG) shares surged approximately 20% after adjusted earnings per share (EPS) of $2.19 exceeded analyst expectations. The jewelry r
America’s Car-Mart, Inc. (NASDAQ: CRMT) reported a 57.3% decline in fiscal first-quarter 2027 revenue to $145.8 million and a net loss of approximately $69.0 million . Capital constraints limited vehicle purchases and customer financing, contributing to an 81.9% decline in
J.Jill (NYSE: JILL) Price Target Raised to $25.00 Following Strong Q2 Earnings BTIG analyst Janine Stichter set a new stock price target of $25.00 for J.Jill, indicating a potential 15.74% upside from its previous trading price. The women's apparel retailer reported robust second
Halper Sadeh LLC says it is investigating whether certain officers and directors of Lululemon Athletica Inc. (NASDAQ: LULU) breached their fiduciary duties to shareholders. BMO Capital Markets analyst Kelly Crago initiated coverage of Lululemon Athletica Inc. (NASDAQ: LULU) with
Cowen & Co. reiterated a "Buy" rating for Meta Platforms, citing its new AI product, Muse, as a potential significant revenue stream. The launch of Muse, an advanced AI agent, led to a 7.20% rally in Meta Platforms' shares, with analysts highlighting its integration capabilit
Core & Main (NYSE:CNM) surpassed analyst expectations for both earnings per share (EPS) and revenue in its fiscal second quarter. The company's growth is significantly driven by robust activity in municipal infrastructure and increasing demand for fire protection products . Core
Korn Ferry (NYSE: KFY) exceeded first-quarter earnings per share and revenue expectations, demonstrating strong operational performance. Despite robust Q1 financial results, the company's stock experienced a decline following conservative guidance for the upcoming quarter, impact
SailPoint's adjusted earnings per share (EPS) of $0.09 surpassed analyst estimates by 12.50% . Despite a slight revenue miss, the company reported $308.81 million in Q2 revenue, marking a 17% year-over-year increase. Strong underlying metrics include a 25% growth in total Annual
The Cooper Companies (NASDAQ: COO) is set to release its Q3 earnings, with analysts projecting $1.12 EPS and $1.10 billion revenue , indicating growth. Despite a recent stock decline to $67.69 , an analyst raised the price target to $80.00 , suggesting future potential. The compa
Wedbush analyst raised the price target for Intellia Therapeutics (NASDAQ: NTLA) , indicating a potential upside. The company's lonvo-z treatment for Hereditary Angioedema (HAE) received FDA Priority Review, setting a target decision date of March 10, 2027. Intellia secured a $40
Signet Jewelers reported strong Q2 fiscal year 2027 financial results, significantly surpassing analyst EPS estimates. Despite a minor revenue miss, the company's stock surged 14% due to an optimistic full-year profit outlook. The specialty jewelry retailer demonstrates healthy f
UBS raised its price target for ABM Industries to $51.50 , indicating potential upside for the facility management solutions provider. ABM Industries achieved a 52-week high following strong quarterly earnings and robust revenue growth , reflecting strong investor confidence . Th
Earnings per share of $0.36 doubled analyst estimates of $0.18 . Quarterly revenue reached $3.33 billion , slightly surpassing analyst expectations. Stock performance was primarily driven by raised net sales guidance, indicating a positive future outlook for the pet e-commerce co
Headlines provided by Investing.com